Tevogen Bio Set to Join Russell 3000 Index

WARREN, N.J., June 12, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. ("Tevogen" or "Tevogen Bio") (NASDAQ:TVGN), a clinical-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically

GlobeNewswireJun 12 15:45 ET

Express News | Tevogen Bio Enters Into Agreement for up to $50 Million in Financing to Advance R&D and Clinical Development Efforts

ReutersJun 11 15:30 ET

CORRECTION – Tevogen Bio Expresses Gratitude to Patients, First Responders, Elected Officials, and Members of the United States Congress for Attending Its Inaugural Post-Public Listing Social Engagement Event

Yahoo FinanceJun 7 15:32 ET

Tevogen Bio Expresses Gratitude to Patients, First Responders, Elected Officials, and Members of the United States Congress for Attending Its Inaugural Post-Listing Social Engagement Event

WARREN, N.J., June 06, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. ("Tevogen" or "Tevogen Bio") (NASDAQ:TVGN), is a clinical-stage specialty immunotherapy company harnessing one of nature's most powerful

GlobeNewswireJun 6 18:14 ET

10-Q: Quarterly report

SEC announcementMay 28 17:26 ET · Announcements

Express News | Tevogen Bio Appoints Former Police Chief & Fbi National Academy Graduate, William Keane, as Vice President of Strategic Initiatives

ReutersMay 16 14:00 ET